达英35和优思悦治疗多囊卵巢综合征的疗效比较

Curative Effect Comparison Between Diane-35 and Drospirenone and Ethinylestradiol Tablets in Treatment of Polycystic Ovary Syndrome

目的 探讨达英35和优思悦治疗多囊卵巢综合征的疗效。方法 选取珠海市香洲区第二人民医院妇产科2022年5月—2023年5月收治的多囊卵巢综合征患者128例作为研究对象,根据奇偶数字抽签法分为参照组和研讨组,每组64例。其中参照组运用优思悦药物进行治疗,研讨组运用达英35治疗方案,主要就其疗效、糖脂代谢指标以及血清性激素等方面开展比较与分析。结果 治疗后研讨组患者的促黄体激素、睾酮低于参照组,促卵泡激素则高于参照组,研讨组与参照组相比糖脂代谢指标值居更低水平,研讨组与参照组相比治疗总有效率居更高水平(P<0.05)。结论 达英35和优思悦治疗多囊卵巢综合征的疗效值得肯定,能够增强避孕药物的药理作用。

Objective To compare and analyze curative effect of diane-35 and drospirenone and ethinylestradiol tablets in treatment of polycystic ovary syndrome.Methods The paper chose 128 patients with polycystic ovary syndrome admitted to Obstetrics and Gynecology Department of Zhuhai City Xiangzhou District the Second People's Hospital from May 2022 to May 2023 as case data for study,and divided them into reference group and study group with odd and even number lottery method,with 64 cases in each group.Reference group was treated with drospirenone and ethinylestradiol tablets,while study group with diane-35 treatment.Effect,glucose and lipid metabolism indicators,and serum sex hormones were compared and analyzed.Results After treatment,levels of luteinizing hormone and testosterone in study group were lower than control group,follicle stimulating hormone was higher than control group.Values of glucose and lipid metabolism indicators in study group were lower than control group.Total effective rate of treatment in study group was higher than control group(P<0.05).Conclusion Diane-35 and drospirenone and ethinylestradiol tablets can achieve recognized curative effect for polycystic ovary syndrome,can enhance pharmacological effect of contraceptives.